{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:26:12Z","timestamp":1792697172730,"version":"4.5.0"},"reference-count":548,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA225520"],"award-info":[{"award-number":["P30CA225520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024521","name":"Oklahoma Tobacco Settlement Endowment Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015309","name":"Tobacco Settlement Endowment Trust","doi-asserted-by":"publisher","award":["R23-02"],"award-info":[{"award-number":["R23-02"]}],"id":[{"id":"10.13039\/100015309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217750","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T14:38:02Z","timestamp":1745678282000},"page":"217750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding"],"prefix":"10.1016","volume":"624","author":[{"given":"Pallab","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Dey Bhowmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan Shankar","family":"Gopinatha Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Kumar Dhar","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-9410","authenticated-orcid":false,"given":"Geeta","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217750_bib1","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626577","article-title":"Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming","volume":"11","author":"Adeshakin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib3","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2025.217750_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101099","article-title":"Targeting anoikis resistance as a strategy for cancer therapy","volume":"75","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.canlet.2025.217750_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Taddei","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217750_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s10495-024-01994-x","article-title":"The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2025.217750_bib7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/odi.14156","article-title":"Long non-coding RNA MRPL23-AS1 suppresses anoikis in salivary adenoid cystic carcinoma in vitro","volume":"29","author":"Li","year":"2023","journal-title":"Oral Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","article-title":"Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis","volume":"39","author":"Khan","year":"2022","journal-title":"Clin Exp Metastas"},{"key":"10.1016\/j.canlet.2025.217750_bib9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/1878-0261.13353","article-title":"PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers","volume":"17","author":"Aakula","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib10","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/0008-5472.CAN-04-2649","article-title":"Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells","volume":"65","author":"Berezovskaya","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib11","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/s41388-018-0384-z","article-title":"CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib12","first-page":"3708","article-title":"Burden of 30 cancers among men: global statistics in 2022 and projections for 2050 using population-based estimates","volume":"130","author":"Bizuayehu","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.canlet.2025.217750_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/cdd.2011.119","article-title":"The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis","volume":"19","author":"Ng","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217750_bib15","first-page":"3062","article-title":"Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells","volume":"61","author":"Jiang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12964-023-01247-5","article-title":"Regulation of anoikis by extrinsic death receptor pathways","volume":"21","author":"Han","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2025.217750_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2025.217750_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/20959","article-title":"Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC","volume":"399","author":"Shimizu","year":"1999","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.canlet.2025.217750_bib19","first-page":"1","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2025.217750_bib20","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1016\/S1074-5521(98)90615-9","article-title":"Caspases: key mediators of apoptosis","volume":"5","author":"Thornberry","year":"1998","journal-title":"Chem Biol"},{"key":"10.1016\/j.canlet.2025.217750_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)80501-2","article-title":"Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3","volume":"90","author":"Zou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib22","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcb.26363","article-title":"Anoikis resistance and oncoviruses","volume":"119","author":"Kakavandi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217750_bib23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1242\/jcs.115.8.1567","article-title":"BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death","volume":"115","author":"Bouillet","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrm2312","article-title":"Apoptosis: controlled demolition at the cellular level","volume":"9","author":"Taylor","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41418-021-00855-3","article-title":"Non-canonical phosphorylation of Bmf by p38 MAPK promotes its apoptotic activity in anoikis","volume":"29","author":"Zhi","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217750_bib26","doi-asserted-by":"crossref","DOI":"10.4161\/auto.26759","article-title":"Is BMF central for anoikis and autophagy?","volume":"10","author":"Delgado","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2025.217750_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1097-2765(00)80456-6","article-title":"The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex","volume":"3","author":"Puthalakath","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib28","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1073\/pnas.0438011100","article-title":"JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis","volume":"100","author":"Lei","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217750_bib29","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1062257","article-title":"Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis","volume":"293","author":"Puthalakath","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217750_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","article-title":"BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis","volume":"8","author":"Cheng","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1074\/jbc.M505546200","article-title":"Evidence that Ser 87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function","volume":"281","author":"Qi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1091\/mbc.11.3.1103","article-title":"The p42\/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal","volume":"11","author":"Le Gall","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-9084(02)01366-4","article-title":"The adenine nucleotide translocator in apoptosis","volume":"84","author":"Belzacq","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.canlet.2025.217750_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molcel.2005.02.003","article-title":"BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly","volume":"17","author":"Kuwana","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0092-8674(00)80450-X","article-title":"Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria","volume":"91","author":"Vander Heiden","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib37","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1038\/s41467-020-17074-y","article-title":"Characterization of an alternative BAK-binding site for BH3 peptides","volume":"11","author":"Ye","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1523-1747.2003.12014.x","article-title":"Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8","volume":"120","author":"Puviani","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2025.217750_bib39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12020-023-03305-x","article-title":"Visfatin induces ovarian cancer resistance to anoikis by regulating mitochondrial activity","volume":"80","author":"Gogola-Mruk","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.canlet.2025.217750_bib40","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1038\/sj.onc.1209753","article-title":"Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1083\/jcb.152.3.633","article-title":"Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-Flip and implications for anoikis","volume":"152","author":"Aoudjit","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.cdd.4401549","article-title":"Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes","volume":"12","author":"Uriarte","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217750_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.543","article-title":"Integrin inhibition promotes atypical anoikis in glioma cells","volume":"5","author":"Silginer","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib44","doi-asserted-by":"crossref","first-page":"d982","DOI":"10.2741\/1114","article-title":"Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility","volume":"8","author":"Hanks","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.canlet.2025.217750_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ceb.2012.06.003","article-title":"ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling","volume":"24","author":"Qin","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/MCB.15.2.954","article-title":"Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases","volume":"15","author":"Calalb","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cellsig.2011.10.005","article-title":"Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities","volume":"24","author":"Zhong","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2025.217750_bib49","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/emboj\/16.10.2783","article-title":"Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B\/Akt cellular survival pathway","volume":"16","author":"Khwaja","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2025.217750_bib50","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/MCB.25.12.5282-5291.2005","article-title":"G1\/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression","volume":"25","author":"Collins","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib51","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/sj.onc.1203711","article-title":"The integrin-linked kinase (ILK) suppresses anoikis","volume":"19","author":"Attwell","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yexcr.2016.05.015","article-title":"beta3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD","volume":"346","author":"Nair","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2025.217750_bib53","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/onc.2010.86","article-title":"Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer","volume":"29","author":"Pontier","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1097-2765(05)00012-2","article-title":"14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation","volume":"6","author":"Datta","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib55","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1038\/s41467-018-05850-w","article-title":"Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin","volume":"9","author":"Haun","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.semcancer.2017.07.007","article-title":"Role of Forkhead Box Class O proteins in cancer progression and metastasis","volume":"50","author":"Kim","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib57","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0092-8674(04)00204-1","article-title":"A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho\/TLE corepressors","volume":"116","author":"Jan","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib58","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","article-title":"Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function","volume":"22","author":"Luciano","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.200106070","article-title":"Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins","volume":"155","author":"Stupack","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib60","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.onc.1209947","article-title":"Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells","volume":"26","author":"Hess","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib61","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1074\/jbc.M511248200","article-title":"Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability","volume":"281","author":"Holinstat","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib62","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(00)81604-9","article-title":"A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth","volume":"94","author":"Wary","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib63","doi-asserted-by":"crossref","first-page":"C1282","DOI":"10.1152\/ajpcell.00075.2012","article-title":"Caveolin-1, antiapoptosis signaling, and anchorage-independent cell growth. Focus on \"Caveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cells\"","volume":"302","author":"Lloyd","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.canlet.2025.217750_bib64","doi-asserted-by":"crossref","first-page":"43061","DOI":"10.1074\/jbc.M405095200","article-title":"Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes","volume":"279","author":"Fouquet","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib65","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1074\/jbc.M114.612754","article-title":"The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment","volume":"290","author":"Rayavarapu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2021.03.011","article-title":"Fibronectin regulates anoikis resistance via cell aggregate formation","volume":"508","author":"Han","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ncb1026","article-title":"Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis","volume":"5","author":"Reginato","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib68","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"64","author":"Elstrom","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1091\/mbc.e07-10-1092","article-title":"Induction of autophagy during extracellular matrix detachment promotes cell survival","volume":"19","author":"Fung","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib71","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/MCB.05164-11","article-title":"PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment","volume":"31","author":"Avivar-Valderas","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib72","article-title":"Anoikis in cell fate, physiopathology, and therapeutic interventions","volume":"5","author":"Mei","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2025.217750_bib73","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1128\/MCB.01342-10","article-title":"A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition","volume":"31","author":"Kumar","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1083\/jcb.200312074","article-title":"Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis","volume":"166","author":"Janes","year":"2004","journal-title":"J. Cell Biol."},{"issue":"Pt 6","key":"10.1016\/j.canlet.2025.217750_bib75","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1242\/jcs.108.6.2241","article-title":"Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling","volume":"108","author":"Breuss","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0714.1997.tb00023.x","article-title":"Changes in the expression of alpha v integrins in oral squamous cell carcinomas","volume":"26","author":"Jones","year":"1997","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib77","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1368-8375(97)00059-6","article-title":"Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions","volume":"34","author":"Garzino-Demo","year":"1998","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1011323608064","article-title":"Integrin laminin receptors and breast carcinoma progression","volume":"6","author":"Mercurio","year":"2001","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.canlet.2025.217750_bib79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0945-053X(02)00002-1","article-title":"Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma","volume":"21","author":"Ramos","year":"2002","journal-title":"Matrix Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib80","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1158\/1078-0432.CCR-05-2223","article-title":"Loss of beta 4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation","volume":"12","author":"Bon","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib81","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1158\/0008-5472.CAN-09-1067","article-title":"Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells","volume":"69","author":"Vitolo","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141919","article-title":"Salinomycin promotes anoikis and decreases the cd44+\/CD24- stem-like population via inhibition of STAT3 activation in MDA-MB-231 cells","volume":"10","author":"An","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib83","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib84","article-title":"Oncoviruses: induction of cancer development and metastasis by increasing anoikis resistance","volume":"9","author":"Amjad","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2025.217750_bib85","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2010.04.008","article-title":"Knockdown of a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells","volume":"296","author":"Takeyama","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib86","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1073\/pnas.1734137100","article-title":"WNT7a induces E-cadherin in lung cancer cells","volume":"100","author":"Ohira","year":"2003","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.canlet.2025.217750_bib87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2010.09.007","article-title":"ZEB1-responsive genes in non-small cell lung cancer","volume":"300","author":"Gemmill","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1615\/CritRevOncog.2016016955","article-title":"Anoikis and EMT: lethal \"liaisons\" during cancer progression","volume":"21","author":"Cao","year":"2016","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.canlet.2025.217750_bib89","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1083\/jcb.146.4.855","article-title":"Exogenous expression of \u03b2-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest","volume":"146","author":"Orford","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib90","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1038\/onc.2014.264","article-title":"Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells","volume":"34","author":"Cai","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2019.05.115","article-title":"Loss of cell-matrix contact increases hypoxia-inducible factor-dependent transcriptional activity in glioma cells","volume":"515","author":"Maurer","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11769-x","article-title":"Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines","volume":"7","author":"Baba","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib93","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1158\/0008-5472.CAN-08-1839","article-title":"Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin","volume":"68","author":"Rohwer","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib94","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/jcb.25527","article-title":"Cancer stem cells protect non-stem cells from anoikis: bystander effects","volume":"117","author":"Kim","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217750_bib95","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5483\/BMBRep.2014.47.3.273","article-title":"Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapy","volume":"47","author":"Kee","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib98","doi-asserted-by":"crossref","first-page":"E1036","DOI":"10.1152\/ajpendo.00151.2012","article-title":"Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration","volume":"303","author":"Caneba","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2025.217750_bib99","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-19-1057","article-title":"Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression","volume":"18","author":"Sawyer","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib100","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3892\/ol.2012.862","article-title":"Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis","volume":"4","author":"Liu","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib101","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41419-019-1532-2","article-title":"Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib102","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1038\/s41467-019-10592-4","article-title":"Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation","volume":"10","author":"van Weverwijk","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib103","doi-asserted-by":"crossref","first-page":"E6556","DOI":"10.1073\/pnas.1703791114","article-title":"CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation","volume":"114","author":"Wright","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217750_bib104","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib105","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1158\/1535-7163.MCT-22-0817","article-title":"SGN-B6A: a new vedotin antibody\u2013drug conjugate directed to integrin beta-6 for multiple carcinoma indications","volume":"22","author":"Lyon","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.217750_bib106","article-title":"The histone H3K27me3 demethylases KDM6A\/B resist anoikis and transcriptionally regulate stemness-related genes","volume":"10","author":"Mohammed","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib107","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.neo.2015.11.003","article-title":"Epigenetic regulation of GDF2 suppresses anoikis in ovarian and breast epithelia","volume":"17","author":"Varadaraj","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2025.217750_bib108","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16844","article-title":"The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L","volume":"5","author":"Pedanou","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2025.217750_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111066","article-title":"Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer","volume":"40","author":"Shonibare","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.18632\/oncotarget.2681","article-title":"Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib111","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-10-3342","article-title":"EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis","volume":"71","author":"Cheng","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4149\/neo_2021_201112N1212","article-title":"LncRNA HOTAIR regulates anoikis-resistance capacity and spheroid formation of ovarian cancer cells by recruiting EZH2 and influencing H3K27 methylation","volume":"68","author":"Dai","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.canlet.2025.217750_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biocel.2012.10.009","article-title":"EZH2 is regulated by ERK\/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells","volume":"45","author":"Ferraro","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib114","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","article-title":"Repression of E-cadherin by the polycomb group protein EZH2 in cancer","volume":"27","author":"Cao","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148615","article-title":"BCL2L1 is regulated by the lncRNA MIR4435-2HG-miR-513a-5p-BCL2L1 ceRNA axis and serves as a biomarker for pancreatic adenocarcinoma treatment and prognosis","volume":"925","author":"Zhu","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2025.217750_bib116","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-01916-w","article-title":"lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells","volume":"21","author":"Lu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.217750_bib117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11596-018-1872-7","article-title":"MiR-21 suppresses anoikis through targeting PDCD4 and PTEN in human esophageal adenocarcinoma","volume":"38","author":"Zhao","year":"2018","journal-title":"Current Medical Science"},{"key":"10.1016\/j.canlet.2025.217750_bib118","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neo.2021.05.015","article-title":"miR-138-5p induces aggressive traits by targeting Trp 53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients","volume":"23","author":"da Cruz","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2025.217750_bib119","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-019-1841-5","article-title":"A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3\/AKT\/NF-kappaB and TIMP3\/MMP9 pathways in cervical cancer cells","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib120","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-12-1959","article-title":"MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/10815589241239577","article-title":"YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the \u03b2-catenin pathway","volume":"72","author":"Chen","year":"2024","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib122","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13046-020-01680-1","article-title":"Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer","volume":"39","author":"Mao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib123","doi-asserted-by":"crossref","first-page":"836","DOI":"10.5009\/gnl15460","article-title":"MicroRNA 141 expression is a potential prognostic marker of biliary tract cancers","volume":"10","author":"Kim","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.canlet.2025.217750_bib124","article-title":"Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejbt.2022.04.006","article-title":"Evaluation of miR-141-3p over-expression in ovarian cancer","volume":"58","author":"Shi","year":"2022","journal-title":"Electron. J. Biotechnol."},{"key":"10.1016\/j.canlet.2025.217750_bib126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0582-2","article-title":"MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12\/Sp1\/survivin axis","volume":"16","author":"Mak","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib127","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-019-03547-2","article-title":"Interactions between microRNA-200 family and Sestrin proteins in endometrial cancer cell lines and their significance to anoikis","volume":"459","author":"Kozak","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217750_bib128","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13046-022-02381-7","article-title":"CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells","volume":"41","author":"Yu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib129","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/abbs\/gmab147","article-title":"MicroRNA-99a-3p\/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization","volume":"53","author":"Gao","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2025.217750_bib130","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/IGC.0000000000000456","article-title":"Up-regulation of miR-204 enhances anoikis sensitivity in epithelial ovarian cancer cell line via brain-derived neurotrophic factor pathway in vitro","volume":"25","author":"Yan","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.20892\/j.issn.2095-3941.2019.0010","article-title":"MicroRNA-6744-5p promotes anoikis in breast cancer and directly targets NAT1 enzyme","volume":"17","author":"Malagobadan","year":"2020","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.canlet.2025.217750_bib132","first-page":"10989","article-title":"MicroRNA-451 dictates the anoikis resistance of osteosarcoma by targeting Rab14","volume":"10","author":"Zhai","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2025.217750_bib133","article-title":"Rab14 act as oncogene and induce proliferation of gastric cancer cells via AKT signaling pathway","volume":"12","author":"Guo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib134","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.7150\/jca.15737","article-title":"Rab14 suppression mediated by MiR-320a inhibits cell proliferation, migration and invasion in breast cancer","volume":"7","author":"Yu","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib135","doi-asserted-by":"crossref","first-page":"16005","DOI":"10.1007\/s13277-016-5420-4","article-title":"Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway","volume":"37","author":"Hou","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2025.217750_bib136","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70155","article-title":"Bone sialoprotein facilitates anoikis resistance in lung cancer by inhibiting miR-150-5p expression","volume":"28","author":"Thuong","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib137","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/abbs\/gmz066","article-title":"MicroRNA-363-3p suppresses anoikis resistance in human papillary thyroid carcinoma via targeting integrin alpha 6","volume":"51","author":"Pan","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2025.217750_bib138","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/abbs\/gmaa102","article-title":"The inhibitory effect of microRNA-1827 on anoikis resistance in lung adenocarcinoma A549 cells via targeting caveolin-1","volume":"52","author":"Guo","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2025.217750_bib139","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1007\/s10620-019-05916-9","article-title":"MiR-525-5p repressed metastasis and anoikis resistance in cervical cancer via blocking UBE2C\/ZEB1\/2 signal Axis","volume":"65","author":"Chen","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2017.10.012","article-title":"MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma","volume":"412","author":"Fu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib141","article-title":"miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib142","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1038\/onc.2016.6","article-title":"The microRNA-23b\/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related","volume":"35","author":"Rice","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib143","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1002\/jcp.27679","article-title":"Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy","volume":"234","author":"Taddei","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2025.217750_bib144","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-018-0813-4","article-title":"Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K\/AKT signaling","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib145","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/cancers12040973","article-title":"Involvement of MicroRNA-296 in the inhibitory effect of epigallocatechin gallate against the migratory properties of anoikis-resistant nasopharyngeal carcinoma cells","volume":"12","author":"Lin","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217750_bib146","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2018.05.062","article-title":"A miR-124\/ITGA3 axis contributes to colorectal cancer metastasis by regulating anoikis susceptibility","volume":"501","author":"Sa","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib147","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.18632\/oncotarget.2956","article-title":"MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib148","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12872","article-title":"Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR-520f-3p production and suppressing MMP7 expression","volume":"75","author":"Nguyen","year":"2023","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.canlet.2025.217750_bib149","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.32604\/biocell.2023.029516","article-title":"MiR-520f-3p inhibits epithelial-mesenchymal transition of colorectal cancer cells by targeting Yes-associated protein 1","volume":"47","author":"Jiang","year":"2023","journal-title":"Biocell"},{"key":"10.1016\/j.canlet.2025.217750_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111141","article-title":"Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42","volume":"118","author":"Liu","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2025.217750_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19768354.2019.1567580","article-title":"The ATP-dependent RNA helicase, DDX42 interacts with paxillin and regulates apoptosis and polarization of Ba\/F3 cells","volume":"23","author":"Sohn","year":"2019","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.canlet.2025.217750_bib152","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-020-01622-x","article-title":"Non-coding RNAs in cancer: platforms and strategies for investigating the genomic \u201cdark matter\u201d","volume":"39","author":"Grillone","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib153","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy048.001","article-title":"A phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas","volume":"29","author":"Harb","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib154","first-page":"2538","article-title":"Non-coding RNAs: a promising target for early metastasis intervention","volume":"136","author":"Xiao","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.canlet.2025.217750_bib155","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2025.217750_bib156","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib157","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.18632\/oncotarget.2251","article-title":"Critical role of STAT3 in melanoma metastasis through anoikis resistance","volume":"5","author":"Fofaria","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib158","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","article-title":"STAT3 phosphorylation at Ser 727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib159","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/oncsis.2013.18","article-title":"Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner","volume":"2","author":"Hu","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib161","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003973","article-title":"Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer","volume":"9","author":"Long","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib162","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1172\/JCI87252","article-title":"Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217750_bib163","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2019-0003","article-title":"Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes","volume":"4","author":"Wilson","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.canlet.2025.217750_bib164","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.29155","article-title":"Metastasis blood test by flow cytometry: in vivo cancer spheroids and the role of hypoxia","volume":"136","author":"Denes","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib165","doi-asserted-by":"crossref","first-page":"111912","DOI":"10.18632\/oncotarget.22951","article-title":"The inhibition of cordycepin on cancer stemness in TGF-beta induced chemo-resistant ovarian cancer cell","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib166","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib167","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/carcin\/bgu233","article-title":"STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells","volume":"36","author":"Fofaria","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib168","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41419-022-04890-x","article-title":"TGF-beta1\/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2\/STAT3 and SHP2\/Grb2 signaling pathways","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib169","article-title":"TGF-beta induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3892\/ol.2013.1108","article-title":"Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells","volume":"5","author":"Chunhacha","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib171","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1593\/neo.101086","article-title":"Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-beta signaling in breast cancer cells","volume":"13","author":"Taylor","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2025.217750_bib172","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI64946","article-title":"TGF-beta upregulates miR-181a expression to promote breast cancer metastasis","volume":"123","author":"Taylor","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217750_bib173","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-23-2823","article-title":"Clinical activity of TGF-\u03b2 inhibitor vactosertib in combination with imatinib in desmoid tumors: a multicenter phase ib\/II study","volume":"30","author":"Ahn","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103653","article-title":"PF-06952229, a selective TGF-\u03b2-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors","volume":"9","author":"Yap","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2025.217750_bib175","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.2613","article-title":"Phase 1 trial of TU2218, TGF\u03b2-RI and VEGF-R2 dual inhibitor in monotherapy and combination with pembrolizumab in patients with advanced solid tumors","volume":"42","author":"Oh","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib176","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12885-024-12216-7","article-title":"First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-\u03b2 receptor I inhibitor, in patients with advanced solid tumors","volume":"24","author":"Guo","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib177","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tox.2014.04.002","article-title":"Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance","volume":"322","author":"Kim","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.canlet.2025.217750_bib178","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2015.06.093","article-title":"Geraniin inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance","volume":"25","author":"Ko","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.canlet.2025.217750_bib179","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/CAD.0000000000000495","article-title":"Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-beta1-induced epithelial-to-mesenchymal transition","volume":"28","author":"Wang","year":"2017","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.canlet.2025.217750_bib180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3727\/096504014X14024160459249","article-title":"Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-kappaB inhibitor, (-)-DHMEQ","volume":"21","author":"Sato","year":"2013","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2025.217750_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311149","article-title":"MCL1 inhibition overcomes the aggressiveness features of triple-negative breast cancer MDA-MB-231 cells","volume":"24","author":"Pratelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049987","article-title":"miR-200c targets a NF-kappaB up-regulated TrkB\/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer","volume":"7","author":"Howe","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib183","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10495-013-0847-1","article-title":"Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-kappaB","volume":"18","author":"Park","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2025.217750_bib184","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jnci\/djk182","article-title":"Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation","volume":"99","author":"Mawji","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2025.217750_bib185","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/0008-5472.CAN-11-3993","article-title":"IKK-epsilon coordinates invasion and metastasis of ovarian cancer","volume":"72","author":"Hsu","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib186","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood.V112.11.2265.2265","article-title":"NF-\u03baB is active in mcl-1 promoter regulation in human CLL","volume":"112","author":"Hertlein","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2025.217750_bib187","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3892\/or.2015.4007","article-title":"DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-kappaB activity","volume":"34","author":"Huan","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib188","doi-asserted-by":"crossref","first-page":"30054","DOI":"10.1074\/jbc.M113.481283","article-title":"Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells","volume":"288","author":"Lee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib189","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcb.29397","article-title":"The anticancer effect of the TLR4 inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: a novel therapeutic potential for breast cancer","volume":"121","author":"Zandi","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217750_bib190","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.onc.1208423","article-title":"Tumor cell invasiveness correlates with changes in integrin expression and localization","volume":"24","author":"Maschler","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib191","article-title":"Galectin-3 inhibitors suppress anoikis resistance and invasive capacity in thyroid cancer cells","volume":"2021","author":"Lee","year":"2021","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.canlet.2025.217750_bib192","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10495-019-01573-5","article-title":"Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells","volume":"24","author":"Guha","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2025.217750_bib193","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12033-024-01061-5","article-title":"Integrin \u03b24 regulates cell migration of lung adenocarcinoma through FAK signaling","volume":"67","author":"Zhang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.canlet.2025.217750_bib194","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41388-023-02885-2","article-title":"VPS35 promotes gastric cancer progression through integrin\/FAK\/SRC signalling-mediated IL-6\/STAT3 pathway activation in a YAP-dependent manner","volume":"43","author":"Zhou","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib195","first-page":"679","article-title":"SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression, 44","author":"Zhai","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib196","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13058-024-01802-z","article-title":"TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via \u03b21-integrin\/FAK-TAZ-mTOR signaling axis by binding to MYH9","volume":"26","author":"Hu","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib197","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.7150\/thno.94207","article-title":"Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling","volume":"14","author":"Jin","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217750_bib198","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s12967-024-05630-9","article-title":"Recycling machinery of integrin coupled with focal adhesion turnover via RAB11-UNC13D-FAK axis for migration of pancreatic cancer cells","volume":"22","author":"Duong","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib199","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/tox.24087","article-title":"Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR-1247-3p-modulated integrin\/FAK axis","volume":"39","author":"Huang","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.canlet.2025.217750_bib200","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju419","article-title":"Simultaneous beta1 integrin-EGFR targeting and radiosensitization of human head and neck cancer","volume":"107","author":"Eke","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2025.217750_bib201","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1535-7163.MCT-13-0484","article-title":"V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells","volume":"13","author":"Schempp","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2025.217750_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104653","article-title":"Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src\/EGFR-dependent ITGB4\/FAK signaling","volume":"61","author":"Wang","year":"2019","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.canlet.2025.217750_bib203","doi-asserted-by":"crossref","first-page":"472","DOI":"10.20945\/2359-3997000000066","article-title":"A brief review about melatonin, a pineal hormone","volume":"62","author":"Amaral","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.canlet.2025.217750_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155714","article-title":"Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR\/Integrin \u03b21\/FAK signaling pathway","volume":"129","author":"Zou","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2025.217750_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176462","article-title":"MFG-E8 induces epithelial-mesenchymal transition and anoikis resistance to promote the metastasis of pancreatic cancer cells","volume":"969","author":"Liu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217750_bib206","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.129.3.831","article-title":"Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase","volume":"129","author":"Guinebault","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib207","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18113","article-title":"ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT\/FBLN2 axis","volume":"28","author":"Shen","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib208","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fonc.2014.00252","article-title":"The PTEN\/PI3K\/AKT pathway in vivo, cancer mouse models","volume":"4","author":"Carnero","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib209","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/bj20031229","article-title":"Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change","volume":"375","author":"Milburn","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2025.217750_bib210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib211","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-17-3024","article-title":"Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells","volume":"78","author":"Rahmani","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib212","first-page":"117","article-title":"Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells","volume":"19","author":"Kanayama","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib213","first-page":"1665","article-title":"Renieramycin M sensitizes anoikis-resistant H460 lung cancer cells to anoikis","volume":"36","author":"Sirimangkalakitti","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib214","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tiv.2018.09.003","article-title":"Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells","volume":"53","author":"Wudtiwai","year":"2018","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.canlet.2025.217750_bib215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.5503","article-title":"Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer","volume":"252","author":"Cheng","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217750_bib216","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/carcin\/bgab117","article-title":"Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance","volume":"43","author":"Xu","year":"2022","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib217","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2025.217750_bib218","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1074\/jbc.M201112200","article-title":"Growth-dependent regulation of mammalian pyrimidine biosynthesis by the protein kinase A and MAPK signaling cascades","volume":"277","author":"Sigoillot","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib219","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106398","article-title":"A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics","volume":"184","author":"Anjum","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2025.217750_bib221","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/MCB.24.16.7059-7071.2004","article-title":"Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II","volume":"24","author":"Boerner","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib222","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/cdd.2008.3","article-title":"Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival","volume":"15","author":"Giannoni","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217750_bib223","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/312558a0","article-title":"Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins","volume":"312","author":"Moelling","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217750_bib224","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/418934a","article-title":"Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status","volume":"418","author":"Rajagopalan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217750_bib225","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ncb1026","article-title":"Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis","volume":"5","author":"Reginato","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib226","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.yexcr.2016.08.019","article-title":"Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK\/ERK pathway","volume":"347","author":"Zhang","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2025.217750_bib227","article-title":"Catechol inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition and stem cell-like properties in hepatocellular carcinoma cells","volume":"10","author":"Lim","year":"2020","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.canlet.2025.217750_bib228","article-title":"3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib229","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1038\/s41598-019-39789-9","article-title":"2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype","volume":"9","author":"O'Neill","year":"2019","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.canlet.2025.217750_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111126","article-title":"HK2 promotes migration and invasion of intrahepatic cholangiocarcinoma via enhancing cancer stem-like cells' resistance to anoikis","volume":"118","author":"Du","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2025.217750_bib231","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.canlet.2025.217750_bib232","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ajpath.2019.05.014","article-title":"The expression of yes-associated protein (YAP) maintains putative cancer stemness and is associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"189","author":"Sugiura","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2025.217750_bib233","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1101\/gad.173435.111","article-title":"Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis","volume":"26","author":"Zhao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217750_bib234","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/or.2020.7859","article-title":"Platelet-derived growth factor-BB mediates pancreatic cancer malignancy via regulation of the Hippo\/Yes-associated protein signaling pathway","volume":"45","author":"Li","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib235","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/1535370220977101","article-title":"YAP activation in melanoma contributes to anoikis resistance and metastasis","volume":"246","author":"Zhao","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.canlet.2025.217750_bib236","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/carcin\/bgac014","article-title":"YAP1 activation promotes epithelial-mesenchymal transition and cell survival of renal cell carcinoma cells under shear stress","volume":"43","author":"Chen","year":"2022","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib237","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301975","article-title":"MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway","volume":"6","author":"Doxtater","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.canlet.2025.217750_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2023.01.080","article-title":"An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells","volume":"649","author":"Nakagawa","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib239","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3892\/or.2015.4200","article-title":"Inhibition of Src family kinases overcomes anoikis resistance induced by spheroid formation and facilitates cisplatin-induced apoptosis in human mesothelioma cells","volume":"34","author":"Eguchi","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2018.10.021","article-title":"HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells","volume":"442","author":"Gupta","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib241","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.21873\/anticanres.14565","article-title":"Curcumol suppresses triple-negative breast cancer metastasis by attenuating anoikis resistance inhibition of skp2-mediated transcriptional addiction","volume":"40","author":"Li","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib242","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41389-020-00247-1","article-title":"BRN2 expression increases anoikis resistance in melanoma","volume":"9","author":"Pierce","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib243","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41429-023-00668-1","article-title":"Amoxetamide A, a new anoikis inducer, produced by combined-culture of Amycolatopsis sp. and Tsukamurella pulmonis","volume":"77","author":"Pan","year":"2024","journal-title":"J. Antibiot."},{"key":"10.1016\/j.canlet.2025.217750_bib244","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.9033","article-title":"AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: an open-label, randomized, multicenter, phase II study","volume":"26","author":"Dummer","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib245","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1078-0432.CCR-09-2483","article-title":"The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1\/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer","volume":"16","author":"Banerji","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib246","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/cncr.25786","article-title":"Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer","volume":"117","author":"Kao","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib247","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1634\/theoncologist.2008-0816","article-title":"FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2","volume":"13","author":"Ryan","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2025.217750_bib248","doi-asserted-by":"crossref","first-page":"S1035","DOI":"10.21037\/tcr.2017.07.08","article-title":"Unraveling the hurdles in the development of HER2-targeted agents for metastatic gastro-esophageal cancer patients","author":"Hierro","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib249","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.4529","article-title":"Molecular biomarker analysis and survival in patients (pts) with advanced urothelial cancer (UC) previously treated with chemotherapy","volume":"37","author":"Szabados","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib250","series-title":"Phase I\/II Study with Lapatinib Plus Trametinib in Patients with Metastatic KRAS Mutant Non-small Cell Lung Cancer","year":"2014"},{"key":"10.1016\/j.canlet.2025.217750_bib251","series-title":"Malignant Glioma or Ependymoma","year":"2004"},{"key":"10.1016\/j.canlet.2025.217750_bib252","series-title":"A Phase I Study of Lapatinib and Cetuximab in Patients with Solid Tumors","year":"2010"},{"key":"10.1016\/j.canlet.2025.217750_bib253","series-title":"A Phase I Dose-Escalation Study on the Safety of Lapatinib with Dose-Dense Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer","year":"2020"},{"key":"10.1016\/j.canlet.2025.217750_bib254","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00262-020-02756-9","article-title":"Merkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts' recommendations","volume":"70","author":"Munhoz","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2025.217750_bib255","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.annonc.2022.02.044","article-title":"35P Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins)","volume":"33","author":"Kim","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib256","series-title":"Multicenter, Phase-IV Clinical Trial to Assess Safety of Osimertinib in Indian Adult Patients with Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-Positive Non-small Cell Lung Cancer (NSCLC)","author":"Prospective","year":"2019"},{"key":"10.1016\/j.canlet.2025.217750_bib257","series-title":"SINGLE ARM STUDY TO EVALUATE THE SAFETY OF DACOMITINIB FOR THE FIRST-LINE TREATMENT OF PARTICIPANTS IN INDIA WITH METASTATIC NON-SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-ACTIVATING MUTATIONS","year":"2020"},{"key":"10.1016\/j.canlet.2025.217750_bib258","series-title":"Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Experienced Disease Progression or Unacceptable Toxicity during Chemotherapy","article-title":"Open-label, phase IV, interventional study to evaluate the efficacy of erlotinib (Tarceva\u00ae) following 4 cycles of platinum-based chemotherapy","author":"Multi-centre","year":"2010"},{"key":"10.1016\/j.canlet.2025.217750_bib259","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.lungcan.2011.02.017","article-title":"Second-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study","volume":"74","author":"Heigener","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib260","series-title":"Cytochrom P450 3A4 and 1A2 Phenotyping for the Individualization of Treatment with Sunitinib or Erlotinib in Cancer Patients","year":"2011"},{"key":"10.1016\/j.canlet.2025.217750_bib261","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12885-018-4283-z","article-title":"Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial","volume":"18","author":"Markoczy","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib262","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1470-2045(12)70117-1","article-title":"Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial","volume":"13","author":"Zhang","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib263","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/bjc.2013.721","article-title":"First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study","volume":"110","author":"Douillard","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib264","series-title":"Multicenter, Non-randomized, Open-Labeled Study to Evaluate the Efficacy of Gefitinib (IRESSA\u00ae) as a Second-Line Therapy in NSCLC Patients","year":"2008"},{"key":"10.1016\/j.canlet.2025.217750_bib265","first-page":"332","article-title":"[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China]","volume":"15","author":"Li","year":"2012","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.canlet.2025.217750_bib266","series-title":"A Single Arm Phase IV Study of Afatinib in Elderly Patients with Stage IV or Recurrent Non-small Cell Lung Cancer Whose Tumors Have Epidermal Growth Factor Receptor (EGFR) Exon 19 Deletions or Exon 21(L858R) Substitution Mutations","year":"2015"},{"key":"10.1016\/j.canlet.2025.217750_bib267","year":"2014"},{"key":"10.1016\/j.canlet.2025.217750_bib268","series-title":"A Phase I Study of MK2206 in Patients with Locally Advanced or Metastatic Solid Tumors","year":"2010"},{"key":"10.1016\/j.canlet.2025.217750_bib269","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1158\/1078-0432.CCR-14-0868","article-title":"Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers","volume":"20","author":"Yap","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-7-1","article-title":"Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin\/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors","volume":"7","author":"Molife","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib271","article-title":"A phase II study of MK-2206 in the treatment of recurrent high-grade serous platinum-resistant ovarian","year":"2011","journal-title":"Fallopian Tube, or Primary Peritoneal Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib272","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cncr.35103","article-title":"A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)","volume":"130","author":"Ho","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib273","series-title":"Multicenter Phase II Study of MK-2206 in Previously Treated Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma","year":"2011"},{"key":"10.1016\/j.canlet.2025.217750_bib274","series-title":"A Phase 2 Study of MK-2206 in Previously Treated Metastatic Colorectal Cancer Patients Enriched for PTEN Loss and PIK3CA Mutation","year":"2013"},{"key":"10.1016\/j.canlet.2025.217750_bib275","series-title":"Pilot Study of the Combination of MK-2206, an AKT Inhibitor, and AZD6244, a MEK Inhibitor, in Patients with Advanced Colorectal Carcinoma","year":"2011"},{"key":"10.1016\/j.canlet.2025.217750_bib276","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/bjh.13603","article-title":"Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma","volume":"171","author":"Oki","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217750_bib277","series-title":"A Phase 2 Study of MK-2206 in Patients with Relapsed or Refractory Diffuse Large-B Cell Lymphoma","year":"2011"},{"key":"10.1016\/j.canlet.2025.217750_bib278","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-13-1978","article-title":"Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia","volume":"20","author":"Konopleva","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib279","series-title":"Pediatric Patients with Recurrent or Refractory Solid Tumors or Leukemia","year":"2010"},{"key":"10.1016\/j.canlet.2025.217750_bib280","series-title":"Phase I\/II Study of the Combination of Bendamustine, Rituximab and MK-2206 in the Treatment of Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma","year":"2011"},{"key":"10.1016\/j.canlet.2025.217750_bib281","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13058-019-1154-8","article-title":"Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and\/or PTEN loss\/PTEN mutation","volume":"21","author":"Xing","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib282","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40425-019-0599-8","article-title":"Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration","volume":"7","author":"Stein","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib283","series-title":"A Phase I Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma","year":"2015"},{"key":"10.1016\/j.canlet.2025.217750_bib284","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyad164","article-title":"A single-arm, open-label phase II study of ONC201 in recurrent\/refractory metastatic breast cancer and advanced endometrial carcinoma","volume":"28","author":"Atkins","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2025.217750_bib285","series-title":"Innovative Therapies for Children with Cancer, F. Ministry of Health","article-title":"Biological medicine for diffuse intrinsic pontine glioma (DIPG) eradication","year":"2022"},{"key":"10.1016\/j.canlet.2025.217750_bib286","series-title":"D. National Institute of Neurological, Stroke","article-title":"A combination therapy trial using an adaptive platform design for children and Young adults with diffuse midline gliomas (DMGs) including diffuse intrinsic pontine gliomas (DIPGs) at initial diagnosis, post-radiation therapy and at time of progression","year":"2021"},{"key":"10.1016\/j.canlet.2025.217750_bib287","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1200\/JCO.2009.23.9749","article-title":"Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I\/II resectable non-small-cell lung cancer","volume":"28","author":"Altorki","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib288","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/1535-7163.MCT-05-0367","article-title":"The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells","volume":"5","author":"Mijatovic","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2025.217750_bib289","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/B:DRUG.0000047103.64335.b0","article-title":"Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor","volume":"23","author":"Marshall","year":"2005","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2025.217750_bib290","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/B:DRUG.0000036687.26604.8c","article-title":"Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors","volume":"22","author":"Undevia","year":"2004","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2025.217750_bib291","article-title":"A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer","volume":"13","author":"Schweizer","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib292","series-title":"Phase 1 Study of Niclosamide (ANA001) in Pediatric Patients with Relapsed and Refractory AML","year":"2021"},{"key":"10.1016\/j.canlet.2025.217750_bib293","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030753","article-title":"NTRK fusions in central nervous system tumors: a rare, but worthy target","volume":"21","author":"Gambella","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib294","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/curroncol28010038","article-title":"Canadian consensus for biomarker testing and treatment of TRK fusion cancer in pediatric patients","volume":"28","author":"Perreault","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib295","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/neuonc\/noab274","article-title":"Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors","volume":"24","author":"Doz","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2019.02.010","article-title":"Randomized phase II trial of abiraterone alone or with dasatinib in men with metastatic castration-resistant prostate cancer (mCRPC)","volume":"17","author":"Dorff","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib297","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S1470-2045(13)70479-0","article-title":"Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial","volume":"14","author":"Araujo","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib298","series-title":"A Phase II Study of Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer","year":"2009"},{"key":"10.1016\/j.canlet.2025.217750_bib299","article-title":"Phase 1b trial evaluating the safety of volociximab in combination with carboplatin, paclitaxel, and bevacizumab in subjects with previously untreated stage IIIB\/IV non","year":"2008","journal-title":"Squamous Non-Small Cell Lung Cancer (NSCLC)"},{"key":"10.1016\/j.canlet.2025.217750_bib300","doi-asserted-by":"crossref","unstructured":"I.B. Vergote, N. Colombo, E. Kutarska, J. Del Campo, C. Pippitt, A. Casado, E. Lengyel, K. Gilder, S. Ho, R.J. Schilder, Phase II study comparing volociximab (an antiangiogenic antibody) and pegylated liposomal doxorubicin (PLD) with PLD alone in recurrent ovarian or primary peritoneal cancer, J. Clin. Oncol., 27 5560-5560.","DOI":"10.1200\/jco.2009.27.15_suppl.5560"},{"key":"10.1016\/j.canlet.2025.217750_bib301","year":"2008"},{"key":"10.1016\/j.canlet.2025.217750_bib302","series-title":"Phase 2 Open-Label Study of Volociximab (M200) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Cancer Not Previously Treated with Chemotherapy","year":"2006"},{"key":"10.1016\/j.canlet.2025.217750_bib303","series-title":"A Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of Volociximab (M200) in Combination with Carboplatin and Paclitaxel in Subjects with Previously Untreated Stage IIIB\/IV Non-small Cell Lung Cancer (NSCLC)","year":"2008"},{"key":"10.1016\/j.canlet.2025.217750_bib304","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/annonc\/mdu474","article-title":"Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I\/II POSEIDON trial","volume":"26","author":"Elez","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib305","series-title":"I. Sfj Pharmaceuticals, D.G. Merck KgaA, A.I.O.S. gGmbH, Academic, U. Community Cancer Research","year":"2018"},{"key":"10.1016\/j.canlet.2025.217750_bib306","series-title":"Colorectal and Ovarian Cancer Patients with Liver Metastases after Failure of Standard Therapy","article-title":"Open-label, dose-escalation study to investigate the safety, tolerability, PD and PK of EMD 525797 using DCE-MRI as a PK measure of response","year":"2009"},{"key":"10.1016\/j.canlet.2025.217750_bib307","series-title":"Double-blind, Multicenter, Phase 2 Study of a Human Monoclonal Antibody to Human Av Integrins (CNTO 95) in Combination with Docetaxel for the First-Line Treatment of Subjects with Metastatic Hormone Refractory Prostate Cancer","author":"Randomized","year":"2007"},{"key":"10.1016\/j.canlet.2025.217750_bib308","series-title":"A Phase I\/Biomarker Study of Bevacizumab in Combination with CNTO 95 in Patients with Refractory Solid Tumors","year":"2009"},{"key":"10.1016\/j.canlet.2025.217750_bib309","series-title":"Subjects with Stage IV Melanoma","article-title":"Multi-Center, blinded, randomized, controlled study of the safety and efficacy of the human monoclonal antibody to human \u03b1 \u03bd integrins (CNTO 95), alone and in combination with dacarbazine","year":"2005"},{"key":"10.1016\/j.canlet.2025.217750_bib310","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","article-title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial","volume":"15","author":"Stupp","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib311","series-title":"A Multicenter, Open-Label, Randomized, Uncontrolled, Phase IIa Trial in Subjects with Recurrent Glioblastoma Multiforme to Investigate the Clinical Activity, Safety, and Tolerability of Cilengitide (EMD 121,974) Administered as a Single Agent","year":"2004"},{"key":"10.1016\/j.canlet.2025.217750_bib312","year":"2008"},{"key":"10.1016\/j.canlet.2025.217750_bib313","series-title":"Methylation of the MGMT Promoter Gene","article-title":"Phase 11 study of cilengitide in combination with concurrent chemotherapy and radiotherapy followed by protracted daily low dose temozolomide and low dose procarbazine D1 - 20 in newly diagnosed glioblastoma without","year":"2010"},{"key":"10.1016\/j.canlet.2025.217750_bib314","series-title":"Asymptomatic Patients with Metastatic Androgen Independent Prostate Cancer","year":"2005"},{"key":"10.1016\/j.canlet.2025.217750_bib315","series-title":"Patients with Non-metastatic Androgen Independent Prostate Cancer","year":"2005"},{"key":"10.1016\/j.canlet.2025.217750_bib316","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/annonc\/mdv219","article-title":"Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)","volume":"26","author":"Vansteenkiste","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib317","series-title":"Recurrent or Progressive and Refractory Childhood High-Grade Glioma","year":"2008"},{"key":"10.1016\/j.canlet.2025.217750_bib318","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(22)00167-4","article-title":"Dual alphaV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study","volume":"7","author":"Dean","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2025.217750_bib319","series-title":"I. National Cancer","article-title":"A phase I\/II study of ATN-161 and carboplatin in adult patients with recurrent intracranial malignant glioma","year":"2006"},{"key":"10.1016\/j.canlet.2025.217750_bib320","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3892\/or.2015.3910","article-title":"Orally active alphavbeta3 integrin inhibitor MK-0429 reduces melanoma metastasis","volume":"33","author":"Pickarski","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib321","series-title":"A Phase I, Randomized, Multicenter, Double-Blind Study of MK0429 in the Treatment of Men with Hormone Refractory Prostate Cancer and Metastatic Bone Disease","year":"2006"},{"key":"10.1016\/j.canlet.2025.217750_bib322","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/noq142","article-title":"Targeted therapy for high-grade glioma with the TGF-beta 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study","volume":"13","author":"Bogdahn","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib323","series-title":"Overcoming Drug Resistance in Metastatic Castration-Resistant Prostate Cancer with Novel Combination of TGF-\u03b2 Receptor Inhibitor LY2157299 and Enzalutamide: a Randomized Multi-Site Phase II Study","year":"2015"},{"key":"10.1016\/j.canlet.2025.217750_bib324","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002068","article-title":"Safety and activity of the TGFbeta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer","volume":"9","author":"Melisi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib325","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00280-019-03807-4","article-title":"TGFbeta receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer","volume":"83","author":"Melisi","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217750_bib326","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/neuonc\/now009","article-title":"A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma","volume":"18","author":"Brandes","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib327","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s10637-020-00910-9","article-title":"Phase 1b\/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma","volume":"38","author":"Wick","year":"2020","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2025.217750_bib328","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/0008-5472.CAN-21-3565","article-title":"A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer","volume":"82","author":"Rodriguez","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib329","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1158\/0008-5472.CAN-17-2789","article-title":"Proteolytic release of the p75NTR intracellular domain by ADAM10 promotes metastasis and resistance to anoikis","volume":"78","author":"Bao","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib330","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s11658-024-00643-0","article-title":"The oncogenic ADAMTS1-VCAN-EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma","volume":"29","author":"Wen","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib331","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00018-024-05215-1","article-title":"Adipose-derived stem cells promote glycolysis and peritoneal metastasis via TGF-beta1\/SMAD3\/ANGPTL4 axis in colorectal cancer","volume":"81","author":"Zhu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib332","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21873\/cgp.20335","article-title":"Prediction of angiopoietin-like protein 4-related signaling pathways in cholangiocarcinoma cells","volume":"19","author":"Aung","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.canlet.2025.217750_bib333","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1541-7786.MCR-18-0989","article-title":"Multifunctional APJ pathway promotes ovarian cancer progression and metastasis","volume":"17","author":"Neelakantan","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib334","article-title":"The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib335","article-title":"ASS1 enhances anoikis resistance via AMPK\/CPT1A-mediated fatty acid metabolism in ovarian cancer","author":"Feng","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib336","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111457","article-title":"GDF15 enhances anoikis resistance and metastasis of gastric cancer through protective autophagy","volume":"124","author":"Gao","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2025.217750_bib337","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI78031","article-title":"ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis","volume":"125","author":"Dey","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217750_bib338","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1158\/2767-9764.CRC-23-0154","article-title":"Activating transcription factor 5 promotes neuroblastoma metastasis by inducing anoikis resistance","volume":"3","author":"Banerjee","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib339","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.7150\/jca.58670","article-title":"Upregulation of V-ATPase by STAT3 activation promotes anoikis resistance and tumor metastasis","volume":"12","author":"Adeshakin","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib340","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.1038\/srep09048","article-title":"TALEN mediated targeted editing of GM2\/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells","volume":"5","author":"Mahata","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib341","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.7150\/ijbs.61790","article-title":"BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma","volume":"17","author":"Mao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib342","doi-asserted-by":"crossref","first-page":"523","DOI":"10.21873\/cgp.20469","article-title":"Targeting Bmi1 for enhancing anoikis sensitivity and inhibiting metastasis in colorectal cancer","volume":"21","author":"Hsu","year":"2024","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.canlet.2025.217750_bib343","doi-asserted-by":"crossref","first-page":"106","DOI":"10.18632\/genesandcancer.53","article-title":"Requirement for BUB1B\/BUBR1 in tumor progression of lung adenocarcinoma","volume":"6","author":"Chen","year":"2015","journal-title":"Genes Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib344","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1159\/000430292","article-title":"Caveolin-1 confers resistance of hepatoma cells to anoikis by activating IGF-1 pathway","volume":"36","author":"Tang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2025.217750_bib345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.abb.2018.03.029","article-title":"Tubeimoside V sensitizes human triple negative breast cancer MDA-MB-231 cells to anoikis via regulating caveolin-1-related signaling pathways","volume":"646","author":"Wang","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2025.217750_bib346","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/onc.2017.10","article-title":"CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis","volume":"36","author":"Hu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib347","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.18632\/oncotarget.13677","article-title":"The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib348","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123472","article-title":"The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner","volume":"10","author":"Gandji","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib349","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/0115680096260614231115192343","article-title":"CT109-SN-38, a novel antibody-drug conjugate with dual specificity for CEACAM5 and 6, elicits potent killing of pancreatic cancer cells","volume":"24","author":"Cardenas","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2025.217750_bib350","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.7150\/thno.25131","article-title":"Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer","volume":"8","author":"Lee","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217750_bib351","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","article-title":"Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBPbeta-mediated PDGFB autocrine and paracrine signaling","volume":"40","author":"Du","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib352","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1096\/fj.201701078R","article-title":"AMPK\/GSK3\u03b2\/\u03b2-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2025.217750_bib353","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.5503","article-title":"Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer","volume":"252","author":"Cheng","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217750_bib354","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216479","article-title":"Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer","volume":"579","author":"Primeaux","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib355","article-title":"Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib356","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/s41388-018-0384-z","article-title":"CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib357","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac171","article-title":"CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the integrin\/FAK\/AKT pathway","volume":"163","author":"Liu","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2025.217750_bib358","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41598-018-37443-4","article-title":"Crabp2 promotes metastasis of lung cancer cells via HuR and integrin beta1\/FAK\/ERK signaling","volume":"9","author":"Wu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib359","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1038\/onc.2015.12","article-title":"ERK-regulated alphaB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo","volume":"34","author":"Malin","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib360","first-page":"737","article-title":"Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer","volume":"53","author":"Okugawa","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib361","first-page":"373","article-title":"Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expression","volume":"8","author":"van de Ven","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.canlet.2025.217750_bib362","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2015.02.021","article-title":"CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis","volume":"361","author":"Xiao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib363","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41419-018-0745-0","article-title":"CXCR1\/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis","volume":"9","author":"Du","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib364","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.543856","article-title":"Detachment activated CyPA\/cd147 induces cancer stem cell potential in non-stem breast cancer cells","volume":"8","author":"Meng","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib365","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101596","article-title":"Obesity promotes gastric cancer metastasis via diacylglycerol acyltransferase 2-dependent lipid droplets accumulation and redox homeostasis","volume":"36","author":"Li","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib366","first-page":"48","article-title":"Mitochondrial DHODH regulates hypoxia-inducible factor 1 expression in OTSCC","volume":"12","author":"Gao","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib367","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.21873\/anticanres.17060","article-title":"Functional role of DUSP6 in the EGFR-mediated progression of head and neck squamous cell carcinoma","volume":"44","author":"Tai","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib368","doi-asserted-by":"crossref","first-page":"209","DOI":"10.21037\/gs-24-44","article-title":"ENO2 promotes anoikis resistance in anaplastic thyroid cancer by maintaining redox homeostasis","volume":"13","author":"Zhang","year":"2024","journal-title":"Gland Surg."},{"key":"10.1016\/j.canlet.2025.217750_bib369","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41419-022-05117-9","article-title":"ErbB2\/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib370","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.7150\/ijbs.100276","article-title":"ESM1 facilitates the EGFR\/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signaling","volume":"20","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib371","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s11596-023-2719-4","article-title":"EZH2 contributes to anoikis resistance and promotes epithelial ovarian cancer peritoneal metastasis by regulating m6A","volume":"43","author":"Wang","year":"2023","journal-title":"Current Medical Science"},{"key":"10.1016\/j.canlet.2025.217750_bib372","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6674204","article-title":"FASN knockdown inhibited anoikis resistance of gastric cancer cells via P-ERK1\/2\/Bcl-xL pathway","volume":"2021","author":"Yu","year":"2021","journal-title":"Gastroenterology Research and Practice"},{"key":"10.1016\/j.canlet.2025.217750_bib373","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5418","article-title":"FOSL1 promotes stem cell-like characteristics and anoikis resistance to facilitate tumorigenesis and metastasis in osteosarcoma by targeting SOX2","volume":"54","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib374","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1038\/onc.2017.177","article-title":"Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with alphaV-Class integrins to promote EMT","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2015.04.008","article-title":"FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition","volume":"363","author":"Zhou","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib376","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/1878-0261.12425","article-title":"The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma","volume":"13","author":"Tan","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib377","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111827","article-title":"EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer","volume":"41","author":"Kang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib378","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/cam4.1212","article-title":"Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression","volume":"6","author":"Nishino","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217750_bib379","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-021-00374-x","article-title":"HBXIP induces anoikis resistance by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis and stabilize Prdx1 in breast cancer","volume":"8","author":"Zhou","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12672-022-00543-9","article-title":"HMMR promotes peritoneal implantation of gastric cancer by increasing cell-cell interactions","volume":"13","author":"Yang","year":"2022","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib381","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2022.07.066","article-title":"Excessive activation of HOXB13\/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance","volume":"623","author":"Tang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib382","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.7150\/ijms.60610","article-title":"HRC promotes anoikis resistance and metastasis by suppressing endoplasmic reticulum stress in hepatocellular carcinoma","volume":"18","author":"Xia","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib383","first-page":"2117","article-title":"High expression of ID1 facilitates metastasis in human osteosarcoma by regulating the sensitivity of anoikis via PI3K\/AKT depended suppression of the intrinsic apoptotic signaling pathway","volume":"11","author":"Zhao","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.canlet.2025.217750_bib384","doi-asserted-by":"crossref","first-page":"78507","DOI":"10.18632\/oncotarget.19659","article-title":"Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib385","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1158\/2159-8290.CD-20-1690","article-title":"Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in ewing sarcoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217750_bib386","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41416-020-0970-z","article-title":"IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src\/FAK signalling in hepatocellular carcinoma","volume":"123","author":"Mo","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib387","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.18632\/oncotarget.7066","article-title":"JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells","volume":"7","author":"Recio-Boiles","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib388","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.apsb.2024.04.024","article-title":"KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2025.217750_bib389","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.2147\/OTT.S142610","article-title":"KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity","volume":"10","author":"Xie","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2025.217750_bib390","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.65","article-title":"Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer","volume":"6","author":"Farrugia","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib391","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.8","article-title":"Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival","volume":"4","author":"Lin","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib392","first-page":"2792","article-title":"L1CAM promotes epithelial to mesenchymal transition and formation of cancer initiating cells in human endometrial cancer","volume":"15","author":"Chen","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib393","doi-asserted-by":"crossref","first-page":"44654","DOI":"10.18632\/oncotarget.17963","article-title":"Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer","volume":"8","author":"Gentilini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib394","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/cas.15687","article-title":"Limb expression 1-like protein promotes epithelial-mesenchymal transition and epidermal growth factor receptor-tyrosine kinase inhibitor resistance via nucleolin-mediated ribosomal RNA synthesis in non-small cell lung cancer","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib395","first-page":"2083","article-title":"LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance","volume":"10","author":"Li","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib396","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101685","article-title":"Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis","volume":"36","author":"Shao","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib397","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3892\/ol.2022.13651","article-title":"Prognostic potential of METTL3 expression in patients with gastric cancer","volume":"25","author":"Okugawa","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2025.217750_bib398","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020247","article-title":"FAM188B downregulation sensitizes lung cancer cells to anoikis via EGFR downregulation and inhibits tumor metastasis in vivo","volume":"13","author":"Jang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217750_bib399","first-page":"3271","article-title":"MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells","volume":"18","author":"Jiang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib400","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1002\/jcp.29377","article-title":"Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma","volume":"235","author":"Zhu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2025.217750_bib401","doi-asserted-by":"crossref","first-page":"66098","DOI":"10.18632\/oncotarget.19802","article-title":"Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer","volume":"8","author":"Suzuki","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib402","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2022.08.010","article-title":"Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer","volume":"253","author":"Bose","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.canlet.2025.217750_bib403","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.7150\/thno.46001","article-title":"Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis","volume":"10","author":"Ye","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217750_bib404","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.1074\/jbc.RA118.003017","article-title":"Cell clustering mediated by the adhesion protein PVRL4 is necessary for alpha6beta 4 integrin-promoted ferroptosis resistance in matrix-detached cells","volume":"293","author":"Brown","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217750_bib405","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12885-018-4507-2","article-title":"IKappaKappaepsilon cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts","volume":"18","author":"House","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib406","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/1541-7786.MCR-14-0334","article-title":"Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2","volume":"13","author":"Brown","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib407","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/cas.14320","article-title":"Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma","volume":"111","author":"Shimokawa","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib408","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1210\/clinem\/dgae687","article-title":"Overexpression of NR1D1 portends disease recurrence in thyroid cancer","volume":"110","author":"Hsu","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2025.217750_bib409","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231161141","article-title":"NRF1 regulates the epithelial mesenchymal transition of breast cancer by modulating ROS homeostasis","volume":"22","author":"Sun","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2025.217750_bib410","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3892\/ijo.2016.3356","article-title":"Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells","volume":"48","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib411","first-page":"621","article-title":"Proliferative role of BDNF\/TrkB signaling is associated with anoikis resistance in cervical cancer","volume":"40","author":"Yuan","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib412","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-023-04960-z","article-title":"TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma","volume":"80","author":"Kim","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib413","doi-asserted-by":"crossref","first-page":"11248","DOI":"10.1002\/jcb.28400","article-title":"Erlotinib inhibits colon cancer metastasis through inactivation of TrkB-dependent ERK signaling pathway","volume":"120","author":"Shen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217750_bib414","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep4.1361","article-title":"OLFM4 enhances STAT3 activation and promotes tumor progression by inhibiting GRIM19 expression in human hepatocellular carcinoma","volume":"3","author":"Ashizawa","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.canlet.2025.217750_bib415","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12935-019-1022-8","article-title":"PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin beta3","volume":"19","author":"Soriano","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.217750_bib416","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-022-02242-3","article-title":"Genome-wide CRISPR\/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib417","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.11.025","article-title":"The PLAG1-GDH1 Axis promotes anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer","volume":"69","author":"Jin","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib418","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41419-023-05618-1","article-title":"Polo-like kinase 4 (Plk4) potentiates anoikis-resistance of p53KO mammary epithelial cells by inducing a hybrid EMT phenotype","volume":"14","author":"Fonseca","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib419","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13046-023-02835-6","article-title":"Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1alpha promotes invasion and metastasis of nasopharyngeal carcinoma","volume":"42","author":"Liao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib420","first-page":"499","article-title":"Effect of peroxisome proliferator-activated receptor-gamma coactivator-1alpha on metastasis and anoikis resistance in colorectal cancer","volume":"38","author":"Lu","year":"2016","journal-title":"Zhonghua Zhongliu Zazhi"},{"key":"10.1016\/j.canlet.2025.217750_bib421","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005931","article-title":"Protein kinase A activation promotes cancer cell resistance to glucose starvation and anoikis","volume":"12","author":"Palorini","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2025.217750_bib422","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13402-019-00460-0","article-title":"Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the beta-catenin\/ID2 pathway","volume":"42","author":"Wang","year":"2019","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib423","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13058-016-0749-6","article-title":"PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells","volume":"18","author":"Byerly","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib424","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/2767-9764.CRC-23-0090","article-title":"MARCH2, a novel oncogene-regulated SNAIL E3 ligase, suppresses triple-negative breast cancer metastases","volume":"4","author":"Ito","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.canlet.2025.217750_bib425","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1158\/0008-5472.CAN-15-3445","article-title":"PTK6 inhibition suppresses metastases of triple-negative breast cancer via SNAIL-dependent E-cadherin regulation","volume":"76","author":"Ito","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib426","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1631\/jzus.B2300154","article-title":"RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer through upregulation of RAD51B","volume":"25","author":"Wei","year":"2024","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.canlet.2025.217750_bib427","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110091","article-title":"FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions","volume":"86","author":"Panigrahi","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2025.217750_bib428","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2016.19","article-title":"The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux","volume":"2","author":"Yoshino","year":"2016","journal-title":"Cell Discov"},{"key":"10.1016\/j.canlet.2025.217750_bib429","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/cam4.1296","article-title":"SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer","volume":"7","author":"Matsumoto","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217750_bib430","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1080\/15548627.2018.1502564","article-title":"Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP\/MDA-9\/Syntenin","volume":"14","author":"Talukdar","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2025.217750_bib431","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jdermsci.2022.12.007","article-title":"Sestrin2 contributes to BRAF inhibitor resistance via reducing redox vulnerability of melanoma cells","volume":"109","author":"Guo","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib432","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7150\/thno.51646","article-title":"The 14-3-3sigma protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1\/2 signaling pathway","volume":"11","author":"Song","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217750_bib433","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/cas.12632","article-title":"Sirtuin 6 promotes transforming growth factor-beta1\/H2O2\/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence","volume":"106","author":"Feng","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib434","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.21873\/anticanres.14565","article-title":"Curcumol suppresses triple-negative breast cancer metastasis by attenuating anoikis resistance via inhibition of skp2-mediated transcriptional addiction","volume":"40","author":"Li","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib435","doi-asserted-by":"crossref","first-page":"32408","DOI":"10.18632\/oncotarget.8717","article-title":"Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib436","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.112062","article-title":"SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer","volume":"578","author":"Kuo","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2025.217750_bib437","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1038\/s41388-020-01451-4","article-title":"Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma","volume":"39","author":"Mehner","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib438","doi-asserted-by":"crossref","first-page":"35737","DOI":"10.18632\/oncotarget.5927","article-title":"Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers","volume":"6","author":"Mehner","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib439","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s10495-024-01994-x","article-title":"The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2025.217750_bib440","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/onc.2016.404","article-title":"Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib441","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217332120","article-title":"Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis","volume":"120","author":"Boese","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217750_bib442","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/onc.2015.148","article-title":"Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein","volume":"35","author":"Tanas","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217750_bib443","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.7150\/ijbs.69933","article-title":"TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib444","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","article-title":"A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer","volume":"75","author":"D'Amato","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib445","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1158\/1535-7163.MCT-19-0181","article-title":"Acquired resistance to EGFR TKIs mediated by TGFbeta1\/integrin beta3 signaling in EGFR-mutant lung cancer","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2025.217750_bib446","doi-asserted-by":"crossref","first-page":"72235","DOI":"10.18632\/oncotarget.19703","article-title":"TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib447","first-page":"821","article-title":"Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer","volume":"42","author":"Yoneura","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib448","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1158\/1541-7786.MCR-22-0415","article-title":"XIAP and PHB1 regulate anoikis through competitive binding to TRAF6","volume":"21","author":"Yang","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib449","article-title":"Targeting TUBB3 suppresses anoikis resistance and bone metastasis in prostate cancer","volume":"13","author":"Dong","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.canlet.2025.217750_bib450","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ebiom.2016.12.014","article-title":"Regulation of XIAP turnover reveals a role for USP11 in promotion of tumorigenesis","volume":"15","author":"Zhou","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2025.217750_bib451","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106122","article-title":"VEGFa\/VEGFR2 autocrine and paracrine signaling promotes cervical carcinogenesis via beta-catenin and snail","volume":"142","author":"Prasad","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib452","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.omto.2021.05.008","article-title":"Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src\/FAK signaling","volume":"22","author":"Liu","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.canlet.2025.217750_bib453","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217750_bib454","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217750_bib455","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41598-019-41552-z","article-title":"Construction and analysis of protein-protein interaction network of heroin use disorder","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.canlet.2025.217750_bib456","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1158\/1535-7163.MCT-19-0181","article-title":"Acquired resistance to EGFR TKIs mediated by tgf\u03b21\/integrin \u03b23 signaling in EGFR-mutant lung cancer","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.217750_bib457","article-title":"VEGF signaling: role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217750_bib458","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1158\/1541-7786.MCR-22-0415","article-title":"XIAP and PHB1 regulate anoikis through competitive binding to TRAF6","volume":"21","author":"Yang","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib459","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422281","article-title":"The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells","volume":"15","author":"Peppicelli","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217750_bib460","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-023-04960-z","article-title":"TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma","volume":"80","author":"Kim","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib461","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.3390\/ijms25115585","article-title":"SIRT6 inhibits anoikis of colorectal cancer cells by down-regulating NDRG1","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib462","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1080\/15384101.2016.1160986","article-title":"Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2025.217750_bib463","article-title":"Targeting TUBB3 suppresses anoikis resistance and bone metastasis in prostate cancer","volume":"13","author":"Dong","year":"2024","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.canlet.2025.217750_bib464","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102544","article-title":"CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis","volume":"58","author":"Tian","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib465","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.69","article-title":"SALL4 promotes gastric cancer progression through activating CD44 expression","volume":"5","author":"Yuan","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2025.217750_bib466","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1158\/1078-0432.CCR-10-2920","article-title":"Adaptive changes result in activation of alternate signaling pathways and acquisition of resistance to aromatase inhibitors","volume":"17","author":"Brodie","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib467","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","article-title":"TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies","volume":"15","author":"Shi","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib468","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022301","article-title":"Targeting TGF-beta signaling for therapeutic gain","volume":"9","author":"Akhurst","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.canlet.2025.217750_bib469","doi-asserted-by":"crossref","first-page":"705","DOI":"10.20892\/j.issn.2095-3941.2020.0290","article-title":"NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma","volume":"18","author":"Yue","year":"2021","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.canlet.2025.217750_bib470","volume":"vol. 2013","author":"Gales","year":"2013"},{"key":"10.1016\/j.canlet.2025.217750_bib471","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.723846","article-title":"CXCL8 in tumor biology and its implications for clinical translation","volume":"9","author":"Xiong","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.canlet.2025.217750_bib472","article-title":"The IL-8\/IL-8R Axis: a double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.canlet.2025.217750_bib473","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2018.00075","article-title":"Deciphering the dichotomous effects of PGC-1alpha on tumorigenesis and metastasis","volume":"8","author":"Gravel","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib474","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib475","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","article-title":"EZH2-Targeted therapies in cancer: hype or a reality","volume":"80","author":"Eich","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib476","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991797","article-title":"CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217750_bib477","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20175","article-title":"Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6","volume":"9","author":"Ren","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2025.217750_bib478","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1111522","article-title":"Emerging functions of C\/EBPbeta in breast cancer","volume":"13","author":"Matherne","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib479","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2020.00221","article-title":"Resistance mechanisms to anti-angiogenic therapies in cancer","volume":"10","author":"Haibe","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib480","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012391","article-title":"New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy","volume":"12","author":"Zhou","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib481","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101396","article-title":"KLF4 suppresses the proliferation and metastasis of NSCLC cells via inhibition of MSI2 and regulation of the JAK\/STAT3 signaling pathway","volume":"22","author":"Luo","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib482","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-020-09890-x","article-title":"Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer","volume":"39","author":"Simon","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2025.217750_bib483","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-020-02792-4","article-title":"Caveolin-1 suppresses tumor formation through the inhibition of the unfolded protein response","volume":"11","author":"Diaz","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib484","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BST20220808","article-title":"Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments","volume":"50","author":"Latham","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.canlet.2025.217750_bib485","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1947601913486349","article-title":"The 2 faces of JNK signaling in cancer","volume":"4","author":"Tournier","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib486","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41419-021-04486-x","article-title":"Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress","volume":"13","author":"Al Haq","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib487","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41419-024-07290-5","article-title":"Targeting TRAF6\/IRF3 axis to inhibit NF-kappaB-p65 nuclear translocation enhances the chemosensitivity of 5-FU and reverses the proliferation of gastric cancer","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217750_bib488","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12935-020-01517-z","article-title":"The relationship between TRAF6 and tumors","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.217750_bib489","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074639","article-title":"TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity","volume":"8","author":"Muto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib490","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2012.01.016","article-title":"PKCepsilon promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria","volume":"148","author":"Lau","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib491","first-page":"8103","article-title":"Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival","volume":"63","author":"Berger","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib492","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc2681","article-title":"Emerging roles of ATF2 and the dynamic AP1 network in cancer","volume":"10","author":"Lopez-Bergami","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib493","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.7824938","article-title":"Transcription factor ATF2 regulation by the JNK signal transduction pathway","volume":"267","author":"Gupta","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217750_bib494","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1073\/pnas.0706057105","article-title":"Suppressor role of activating transcription factor 2 (ATF2) in skin cancer","volume":"105","author":"Bhoumik","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217750_bib495","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1158\/0008-5472.CAN-06-4037","article-title":"Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21\/Cip1-dependent manner","volume":"67","author":"Bae","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib496","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055820","article-title":"Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma","volume":"8","author":"Proctor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217750_bib497","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.02.003","article-title":"Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma","volume":"20","author":"Chen","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217750_bib498","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1471-4906(03)00241-2","article-title":"Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1","volume":"24","author":"Raaphorst","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2025.217750_bib499","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells","volume":"423","author":"Park","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217750_bib500","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.05.009","article-title":"Bmi1 is required for regeneration of the exocrine pancreas in mice","volume":"143","author":"Fukuda","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2025.217750_bib501","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/path.5152","article-title":"Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth","volume":"246","author":"Thijssen","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217750_bib502","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI200318549","article-title":"Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors","volume":"112","author":"Abramsson","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217750_bib503","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117212","article-title":"Dehydrodiisoeugenol inhibits PDGF-BB-induced proliferation and migration of human pulmonary artery smooth muscle cells via the mTOR\/HIF1-alpha\/HK2 signaling pathway","volume":"495","author":"Xie","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217750_bib504","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib505","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1158\/1078-0432.CCR-07-1893","article-title":"Combination of vascular endothelial growth factor receptor\/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy","volume":"14","author":"Timke","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib506","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41416-024-02683-x","article-title":"SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration","volume":"130","author":"Wang","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib507","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2147\/OTT.S154215","article-title":"SPP1 promotes ovarian cancer progression via Integrin beta1\/FAK\/AKT signaling pathway","volume":"11","author":"Zeng","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2025.217750_bib508","first-page":"15","article-title":"The significance of SPP1 in lung cancers and its impact as a marker for protumor tumor-associated macrophages","author":"Matsubara","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217750_bib509","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","article-title":"Fatty acid synthase (FASN) as a therapeutic target in breast cancer","volume":"21","author":"Menendez","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2025.217750_bib510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100660","article-title":"Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN\/APP axis as novel therapeutic strategies","volume":"65","author":"Chen","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.canlet.2025.217750_bib511","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1349-7006.2010.01596.x","article-title":"Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice","volume":"101","author":"Murata","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib512","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2407-12-280","article-title":"Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer","volume":"12","author":"Relat","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib513","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1158\/1078-0432.CCR-16-2770","article-title":"Overexpressed fatty acid synthase in gastrointestinal stromal tumors: targeting a progression-associated metabolic driver enhances the antitumor effect of imatinib","volume":"23","author":"Li","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib514","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030562","article-title":"Enhanced de novo lipid synthesis mediated by FASN induces chemoresistance in colorectal cancer","volume":"15","author":"Han","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217750_bib515","first-page":"69","article-title":"Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis\/prognosis marker","volume":"1","author":"Liu","year":"2010","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.canlet.2025.217750_bib516","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib517","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature11689","article-title":"Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis","volume":"493","author":"Knobloch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217750_bib518","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1126\/science.288.5475.2379","article-title":"Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors","volume":"288","author":"Loftus","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217750_bib519","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1073\/pnas.132128899","article-title":"C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity","volume":"99","author":"Thupari","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217750_bib520","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1158\/1078-0432.CCR-07-1186","article-title":"Selective inhibition of fatty acid synthase for lung cancer treatment","volume":"13","author":"Orita","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217750_bib521","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217750_bib522","doi-asserted-by":"crossref","first-page":"24787","DOI":"10.18632\/oncotarget.25361","article-title":"Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer","volume":"9","author":"Zaytseva","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217750_bib523","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ebiom.2016.12.012","volume":"16","author":"Heuer","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2025.217750_bib524","first-page":"1","article-title":"Immune-regulating camouflaged nanoplatforms: a promising strategy to improve cancer nano-immunotherapy","volume":"21","author":"Chen","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.canlet.2025.217750_bib525","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s00262-023-03496-2","article-title":"Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment","volume":"72","author":"Maldonado","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2025.217750_bib526","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120631","article-title":"Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy","volume":"3","author":"Gyori","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2025.217750_bib527","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.787307","article-title":"The colony stimulating factor-1 receptor (CSF-1R)-Mediated regulation of microglia\/macrophages as a target for neurological disorders (glioma, stroke)","volume":"12","author":"Barca","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217750_bib528","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32626","article-title":"Mitochondrial dysfunction significantly contributes to the sensitivity of tumor cells to anoikis and their metastatic potential","volume":"10","author":"Solyanik","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2025.217750_bib529","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5483\/BMBRep.2023-0225","article-title":"Gefitinib induces anoikis in cervical cancer cells","volume":"57","author":"Jung","year":"2024","journal-title":"BMB Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib530","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12915-024-01942-w","article-title":"Vimentin-mediated buffering of internal integrin \u03b21 pool increases survival of cells from anoikis","volume":"22","author":"Jang","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.canlet.2025.217750_bib531","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.07.014","article-title":"Cell clustering promotes a metabolic switch that supports metastatic colonization","volume":"30","author":"Labuschagne","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217750_bib532","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121620","article-title":"Spheroid culture system methods and applications for mesenchymal stem cells","volume":"8","author":"Ryu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2025.217750_bib533","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.omtn.2023.03.011","article-title":"Self-transfecting GMO-PMO chimera targeting Nanog enable gene silencing in vitro and suppresses tumor growth in 4T1 allografts in mouse","volume":"32","author":"Das","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.canlet.2025.217750_bib534","article-title":"Multicellular ovarian cancer spheroids: novel 3D model to mimic tumour complexity","volume":"14","author":"Fl\u00f6rkemeier","year":"2024","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.canlet.2025.217750_bib535","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010090","article-title":"Dietary fucoxanthin induces anoikis in colorectal adenocarcinoma by suppressing integrin signaling in a murine colorectal cancer model","volume":"9","author":"Terasaki","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.canlet.2025.217750_bib536","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrclinonc.2010.171","article-title":"Molecular mechanisms of metastasis in breast cancer\u2014clinical applications","volume":"7","author":"Mego","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217750_bib537","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10585-018-9902-1","article-title":"Breast cancer metastasis through the lympho-vascular system","volume":"35","author":"Nathanson","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2025.217750_bib538","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","article-title":"Progression and metastasis of lung cancer","volume":"35","author":"Popper","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2025.217750_bib539","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2003.10.012","article-title":"Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location","volume":"44","author":"Kotoulas","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2025.217750_bib540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-023-02854-5","article-title":"Tumor microenvironment in ovarian cancer peritoneal metastasis","volume":"23","author":"Mei","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.217750_bib541","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73150","article-title":"Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness","volume":"11","author":"Fanfone","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2025.217750_bib542","first-page":"711","article-title":"CXCR4\/SDF-1alpha-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma","volume":"26","author":"Gros","year":"2012"},{"key":"10.1016\/j.canlet.2025.217750_bib543","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041886","article-title":"The in vivo selection method in breast cancer metastasis","volume":"22","author":"Nakayama","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217750_bib544","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.canlet.2025.217750_bib545","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.7150\/thno.33275","article-title":"Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217750_bib546","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0975","article-title":"From breast cancer cell homing to the onset of early bone metastasis: the role of bone (re)modeling in early lesion formation","volume":"10","author":"Young","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2025.217750_bib547","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1038\/s41598-024-59052-0","article-title":"Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model","volume":"14","author":"Bastian","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217750_bib548","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4161\/cbt.11.2.14623","article-title":"Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity","volume":"11","author":"Zhang","year":"2011","journal-title":"Cancer Biol. Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T14:30:38Z","timestamp":1747405838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":548,"alternative-id":["S0304383525003167"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217750","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217750"}}